Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Prescription Drugs & Other Medical Products

Reports

Displaying 21 - 30 of 112. 10 per page. Page 3.

Advanced Search

Psychosocial Supports in Medication-Assisted Treatment: Recent Evidence and Current Practice

July 7, 2019
ABSTRACT This report was included as Appendix B of "Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions." That report's purpose was to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.
ASPE Issue Brief

Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief

July 7, 2019
Westat Printer Friendly Version in PDF Format (3 PDF pages)
Report

Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions

July 7, 2019
The purpose of this report is to gain a better understanding of the role and range of different models of psychosocial support in medication-assisted treatment for opioid use disorder.

Psychosocial Supports in Medication-Assisted Treatment: Site Visit Findings and Conclusions

July 2, 2019
July 2019 Printer Friendly Version in PDF Format (47 PDF pages)
ASPE Issue Brief

Optimal Utilization of Psychosocial Supports in Medication-Assisted Treatment for Opioid Use Disorder Issue Brief

July 2, 2019
As the opioid epidemic has evolved into a national crisis, the need for treatment has increased greatly. Medication-assisted treatment (MAT) is a “whole-patient” approach to the treatment of opioid use disorder (OUD) that combines the use of medications and psychosocial supports, such as therapy, counseling, self-help groups, and case management.

Choice Matters: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder

June 23, 2019
The purpose of the Opioid Use Disorder, Housing Instability and Housing Options for Recovery project was to help ASPE and HUD describe the housing models available for individuals with Opioid Use Disorder (OUD) who experience housing instability or homelessness.

Choices Matter: Housing Models that May Promote Recovery for Individuals and Families Facing Opioid Use Disorder

June 23, 2019
ASPE recently completed a research project, conducted by Abt Associates, that explored homelessness and opioid use disorder, along with the evidence base for different models for care. This brief is highlights of findings from the project.

Public Listing Status of Data-Waivered Providers: Data Brief

June 2, 2019
Printer Friendly Version in PDF Format (3 PDF pages)
ASPE Issue Brief

Assessing the Costs and Benefits of Extending Coverage of Immunosuppressive Drugs under Medicare

May 9, 2019
By statute, the majority of patients with end-stage renal disease (ESRD) are eligible for Medicare, regardless of age. Kidney transplantation is ultimately considered the best treatment for ESRD, but ESRD-related eligibility for Medicare coverage extends for only 36 months post-transplant.

Identifying Safety-Net Resources at Health Centers to Prevent Infectious Disease Transmission Resulting from the Opioid Epidemic

March 21, 2019
The impact of the opioid epidemic on infectious disease transmission is an important public health issue. The problem came dramatically to light in 2015 when an outbreak of new human immunodeficiency virus (HIV) infections occurred in rural Scott County, Indiana.